SCHEMBL3948449

SCHEMBL3948449

CC(=O)ON(Cc1ccc(-c2ccc3[nH]ccc3c2)cc1)C1Cc2ccccc2C1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ENPP2 Q13822 1/20 0.47
NPC1 O15118 1/20 0.42
PTGS2 P35354 1/20 0.40
EPHX1 P07099 1/20 0.40
CYP2D6 P10635 1/20 0.40
EPHX2 P34913 1/20 0.40
CYP17A1 P05093 1/20 0.39
CYP11B1 P15538 1/20 0.39
CYP11B2 P19099 1/20 0.39
HDAC2 Q92769 1/20 0.39
ABCB1 P08183 1/20 0.39
SLC6A2 P23975 3/20 0.38
SLC6A4 P31645 3/20 0.38
SLC6A3 Q01959 3/20 0.38
CHRNB2 P17787 1/20 0.36
CHRNB4 P30926 1/20 0.36
CHRNA3 P32297 1/20 0.36
CHRNA7 P36544 1/20 0.36
CHRNA4 P43681 1/20 0.36
CHRNA10 Q9GZZ6 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3038342 0.80 ENPP2 (0.41) ENPP2NPC1EPHX1CYP2D6EPHX2
SCHEMBL3051703 0.76 PPARD (0.36) ENPP2EPHX1CYP2D6EPHX2SLC6A2
Acetic Acid SCHEMBL3948445 0.74 HDAC1 (0.52) ENPP2NPC1PTGS2EPHX1CYP2D6
Acetic Acid SCHEMBL3038340 0.74 HDAC1 (0.52) ENPP2NPC1PTGS2EPHX1CYP2D6
SCHEMBL28972109 0.70 SLC6A2 (0.44) SLC6A2SLC6A4SLC6A3HSD11B1
SCHEMBL13137256 0.69 NPC1 (0.52) ENPP2NPC1EPHX1CYP2D6EPHX2
SCHEMBL31369576 0.65 PTGS2 (0.58) ENPP2NPC1PTGS2CYP17A1CYP11B1
SCHEMBL13802501 0.65 ENPP2 (0.66) ENPP2NPC1PTGS2EPHX1CYP2D6
SCHEMBL28743903 0.65 PTGS2 (0.48) ENPP2NPC1PTGS2EPHX1CYP2D6
SCHEMBL19391065 0.65 PTGS2 (0.60) ENPP2NPC1PTGS2CYP17A1CYP11B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2049481-A2 NOVEL COMPOUNDS AS ANTAGONISTS OR INVERSE AGONISTS FOR OPIOID RECEPTORS SmithKline Beecham Corporation (US) 2009-04-22 EP disclosed
WO-2008021851-A2 NOVEL COMPOUNDS AS ANTAGONISTS OR INVERSE AGONISTS FOR OPIOID RECEPTORS SMITHKLINE BEECHAM CORPORATION (US) 2008-02-21 WO disclosed